Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer

BACKGROUND: Transurethral resection of the bladder tumor with or without adjuvant intravesical instillation (IVI) has been the standard treatment for non-muscle-invasive bladder cancer (NMIBC), whereas a high percentage of patients still experience local tumor recurrence and disease progression afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Li, Deng, Xiaobin, Xia, Wentao, Wang, Kun, Zhang, Yang, Zhang, Yan, Shao, Xianfeng, Wang, Junqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706099/
https://www.ncbi.nlm.nih.gov/pubmed/36458001
http://dx.doi.org/10.3389/fimmu.2022.1070043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706099/
https://www.ncbi.nlm.nih.gov/pubmed/36458001
http://dx.doi.org/10.3389/fimmu.2022.1070043

Ejemplares similares